Sapient Capital LLC Takes $247,000 Position in American Well Co. (NYSE:AMWL)

Sapient Capital LLC acquired a new position in American Well Co. (NYSE:AMWL) in the 4th quarter, Holdings Channel.com reports. The firm acquired 165,888 shares of the company’s stock, valued at approximately $247,000.

A number of other institutional investors also recently bought and sold shares of AMWL. Captrust Financial Advisors increased its position in American Well by 1.6% in the second quarter. Captrust Financial Advisors now owns 150,442 shares of the company’s stock worth $650,000 after buying an additional 2,353 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in American Well by 2.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 110,356 shares of the company’s stock worth $312,000 after acquiring an additional 3,160 shares during the period. Legal & General Group Plc lifted its holdings in American Well by 1.7% during the fourth quarter. Legal & General Group Plc now owns 190,120 shares of the company’s stock valued at $538,000 after purchasing an additional 3,238 shares in the last quarter. Point72 Hong Kong Ltd boosted its position in shares of American Well by 175.1% in the first quarter. Point72 Hong Kong Ltd now owns 8,087 shares of the company’s stock worth $34,000 after purchasing an additional 5,147 shares during the period. Finally, Verition Fund Management LLC increased its stake in shares of American Well by 27.6% in the first quarter. Verition Fund Management LLC now owns 24,522 shares of the company’s stock worth $103,000 after purchasing an additional 5,300 shares in the last quarter. 56.05% of the stock is owned by institutional investors.

American Well Trading Down 3.1 %

NYSE:AMWL opened at $0.56 on Tuesday. The stock has a 50-day moving average price of $0.95 and a 200 day moving average price of $1.12. The stock has a market capitalization of $161.23 million, a P/E ratio of -0.23 and a beta of 1.00. American Well Co. has a 12-month low of $0.54 and a 12-month high of $2.74.

American Well (NYSE:AMWL) last announced its quarterly earnings data on Wednesday, February 14th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.02. American Well had a negative net margin of 260.63% and a negative return on equity of 40.19%. The business had revenue of $70.68 million during the quarter, compared to analyst estimates of $70.16 million. During the same period last year, the firm posted ($0.22) EPS. The company’s revenue was down 10.8% on a year-over-year basis. On average, research analysts predict that American Well Co. will post -0.7 earnings per share for the current fiscal year.

Insider Buying and Selling at American Well

In other news, insider Kathy Johnson Weiler sold 283,192 shares of American Well stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $1.09, for a total value of $308,679.28. Following the sale, the insider now directly owns 3,975,617 shares of the company’s stock, valued at $4,333,422.53. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CFO Robert Shepardson sold 319,214 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $1.09, for a total transaction of $347,943.26. Following the sale, the chief financial officer now owns 2,845,148 shares of the company’s stock, valued at $3,101,211.32. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Kathy Johnson Weiler sold 283,192 shares of American Well stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $1.09, for a total transaction of $308,679.28. Following the completion of the transaction, the insider now directly owns 3,975,617 shares of the company’s stock, valued at $4,333,422.53. The disclosure for this sale can be found here. Insiders sold 1,169,038 shares of company stock valued at $1,267,410 in the last 90 days. Insiders own 12.94% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley lowered their target price on shares of American Well from $1.75 to $1.00 and set an “equal weight” rating on the stock in a research note on Monday.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.